The EPN Webinar Series

October

Improving efficiency in procurement of quality assured medicines across the faith-based pharmaceutical supply system in LMICs

Presentation slides

1. WHO’s experience in improving efficiency in Procurement in healthcare systems,Lisa Hedman, Senior Advisor, WHO 
2. Best quality assurance practices in procurement, Shushan Tedla,Quality Assurance, and Pharmaceutical Consultancy  - Open
3. Pooled procurement initiatives in Africa, lessons for DSOs from the current Covid-19 pandemic, Bildard Baguma, Executive Director, Joint Medical Store  - Open

Video Recording

____________________________________________________________________________________________________________________

July

Rethinking assumptions about generic medicines cost and perceived quality: How managerial and regulatory systems help assure quality of generic medicines (Joint EPN and PQM+ webinar)

Presentation slides

1. Discuss generic medicines and why they are important. Managerial and regulatory strategies for assuring quality of generic medicines, Daniel Karimi, Senior Technical Advisor, Chemistry, Manufacturing & Controls (CMC) & Regulatory Systems Strengthening (RSS), PQM+ - Open
2. Managerial strategies for assuring quality of generic medicines: MEDS experience in medicines quality assurance in supply chain management and quality perceptions of generic medicines, Stephen Kigera, Head of Quality Services, MEDS - Open
3. Regulatory strategies for assuring quality of generic medicines: Towards sustainable local supply of quality-assured generic medicines,  Teferi Bedane, Technical Advisor, PQM+ - Open

Video recording
Responses to questions

___________________________________________________________________________________________________________________

May

Capacity building of pharmaceutical staff in church Health institutions: gaps and way forward

Presentation slides

1. MEDS Experience Capacity Building - Agnes Njue, Capacity Building Manager, MEDS - Open
2. EPN renewed capacity building approach - Richard Neci (Executive Director, EPN) - Open
3. Capacity building of pharmaceutical staff in church Health institutions: gaps and way forward - Prof. Richard Laing’, Global Health Expert, Boston University, USA - Open

Video recording

Referenced resources

1. Pharmaceutical human resources in church health services in Africa- EPN HR Mapping study
2. WHO/EPN study on Multi-Country Study of Medicine Supply and Distribution Activities of Faith-Based Organizations in Sub-Saharan African Countries

___________________________________________________________________________________________________________________

February

Enhancing the delivery of good quality pharmaceutical services and products in the context of global challenge of the COVID-19

Report

Presentation slides

Day 1: Monday, February 22

1. Medicinal products supply chain in the Church Health Systems – access to the COVID-19 vaccine: Marlon Banda, Chief of Pharmacy Services & Logistics of the Churches Health Association of Zambia (CHAZ), and EPN Board Chairperson- Open
2. The impact of regulations on health care supply chains: Francis Aboagye-Nyame, Program Director, MTaPS Program; Practice area lead, Pharmaceutical systems strengthening- Open
3. Disruptions of pharmaceutical supply in the COVID-19 global context: manufacturing, availability, affordability, distribution, and prioritization: Raffaella Ravinetto- Senior researcher and policy advisor at ITM Public Health Department- Open
4. Managing the entire supply chain proactively in the new normal (DSO: Availability at the distribution center level): Jane Masiga - Managing Director, Mission for Essential Drugs and Supplies (MEDS) - Open

Day 2: Tuesday, February 23

1. Communication in health systems strengthening: Christoph Bonsmann- Executive Director of Action Medeor International Healthcare, and EPN Board ViceChairperson  - Open
2. Communication and information sharing in the pharmaceutical settings of the pandemic: improvements for agile decision-making processes: Dominique Jordan- President, International Pharmaceutical Federation (FIP) - Open
3. Data management and information sharing in Supply Chain disruptions due to the pandemic (Communication with stakeholders in Pharmaceutical system strengthening): Pamela Steele, Supply Chain Transformation Director, PSA - Open

Day 1 & 2 video recordings

Referenced resources

1. EPN Essentials of Pharmacy Practice Syllabus: https://www.epnetwork.org/centre-of-excellence/essentials-of-pharmacy-practice-syllabus/
2. Evidence on interventions of COVID-19: www.covid-evidence.org
3. FIP Health Advisory: CORONAVIRUS SARS-CoV-2 OUTBREAK: Information and Interim guidelines for pharmacists and pharmacy workforce: https://www.fip.org/files/content/priority-areas/coronavirus/Coronavirus-guidance-update-ENGLISH.pdf
4. FIP  Health Advisory-COVID-19: Guidelines: Evaluation of Diagnostic testing methods and devices: https://www.fip.org/publications?publicationCategory=97&publicationYear=2020&publicationKeyword=
5. Essentials of Pharmaceutical Practice handbook- Available in EPN library on request
6. Where there are no Pharmacists: Available in EPN library on request
7. Multi-country study supply and distribution sub-Sahara - Available in EPN library on request
8. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00306-8/fulltext:
9. COVID-19 and risks to the supply and quality of tests, drugs, and vaccine: https://doi.org/10.1016/S2214-109X(20)30136-4
10. Medical Product Quality Reports: https://www.iddo.org/mq/research/medical-product-quality-reports
11. Drug supply shortage in Nigeria during COVID-19: efforts and challenges: https://joppp.biomedcentral.com/articles/10.1186/s40545-021-00302-1
12. Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges: https://joppp.biomedcentral.com/articles/10.1186/s40545-021-00301-2
13. Strengthening regulatory systems for medicines in a changed world: where do we go from here?: https://gh.bmj.com/content/6/1/e004680
14. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30288-6/fulltext
15. COVID-19 therapeutics: how to sow confusion and break public trust during international public health emergencies: https://joppp.biomedcentral.com/articles/10.1186/s40545-020-00244-0
16. Universal health coverage and COVID-19: recent developments and implications: https://joppp.biomedcentral.com/articles/10.1186/s40545-021-00306-x
17. Role in the Medical Product Supply Chain and Considerations During COVID-19: https://crsre